Beta Drugs Limited (NSE:BETA)

Revenue by Product

Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	NaN - NaN
Oncology Medicines	2.96B	Log In	Log In	Log In	Log In	Upgrade
Oncology Medicines Growth	30.21%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	NaN - NaN
India	2.96B	Log In	Log In	Log In	Log In	Upgrade
India Growth	30.21%	Log In	Log In	Log In	Log In	Upgrade